Tiara C Willie1, Jamila K Stockman2, Danya E Keene3, Sarah K Calabrese4, Kamila A Alexander5, Trace S Kershaw3. 1. Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT. 2. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA. 3. Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT. 4. Department of Psychology, George Washington University, Washington, DC. 5. Department of Community-Public Health Nursing, Johns Hopkins School of Nursing, Baltimore, MD.
Abstract
BACKGROUND: In the United States, women represent less than 5% of all pre-exposure prophylaxis (PrEP) users. Social networks may promote and/or inhibit women's PrEP awareness, which could influence PrEP intentions. Furthermore, women experiencing intimate partner violence (IPV) may have smaller, less supportive networks, which could deter or have no impact on PrEP care engagement. This study examined associations between network characteristics and women's PrEP awareness, interest, uptake, and perceived candidacy and analyzed IPV as an effect modifier. SETTING/ METHODS: From 2017 to 2018, data were collected from a prospective cohort study of 218 PrEP-eligible women with (n = 94) and without (n = 124) IPV experiences in Connecticut. Women completed surveys on demographics, IPV, social networks, and PrEP care continuum outcomes. RESULTS: Adjusted analyses showed that PrEP awareness related to having more PrEP-aware alters. PrEP intentions related to having more alters with favorable opinions of women's potential PrEP use and a smaller network size. Viewing oneself as an appropriate PrEP candidate related to having more PrEP-aware alters and more alters with favorable opinions of women's potential PrEP use. IPV modified associations between network characteristics and PrEP care. Having members who were aware of and/or used PrEP was positively associated with PrEP care engagement for women without IPV experiences but had either no effect or the opposite effect for women experiencing IPV. CONCLUSION: Improving PrEP attitudes might improve its utilization among women. Social network interventions might be one way to increase PrEP uptake among many US women but may not be as effective for women experiencing IPV.
BACKGROUND: In the United States, women represent less than 5% of all pre-exposure prophylaxis (PrEP) users. Social networks may promote and/or inhibit women's PrEP awareness, which could influence PrEP intentions. Furthermore, women experiencing intimate partner violence (IPV) may have smaller, less supportive networks, which could deter or have no impact on PrEP care engagement. This study examined associations between network characteristics and women's PrEP awareness, interest, uptake, and perceived candidacy and analyzed IPV as an effect modifier. SETTING/ METHODS: From 2017 to 2018, data were collected from a prospective cohort study of 218 PrEP-eligible women with (n = 94) and without (n = 124) IPV experiences in Connecticut. Women completed surveys on demographics, IPV, social networks, and PrEP care continuum outcomes. RESULTS: Adjusted analyses showed that PrEP awareness related to having more PrEP-aware alters. PrEP intentions related to having more alters with favorable opinions of women's potential PrEP use and a smaller network size. Viewing oneself as an appropriate PrEP candidate related to having more PrEP-aware alters and more alters with favorable opinions of women's potential PrEP use. IPV modified associations between network characteristics and PrEP care. Having members who were aware of and/or used PrEP was positively associated with PrEP care engagement for women without IPV experiences but had either no effect or the opposite effect for women experiencing IPV. CONCLUSION: Improving PrEP attitudes might improve its utilization among women. Social network interventions might be one way to increase PrEP uptake among many US women but may not be as effective for women experiencing IPV.
Authors: Jeffrey T Parsons; H Jonathon Rendina; Jonathan M Lassiter; Thomas H F Whitfield; Tyrel J Starks; Christian Grov Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731
Authors: Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan Journal: Ann Epidemiol Date: 2018-06-15 Impact factor: 3.797
Authors: Charlene A Flash; Valerie E Stone; Jennifer A Mitty; Matthew J Mimiaga; Kathryn T Hall; Douglas Krakower; Kenneth H Mayer Journal: AIDS Patient Care STDS Date: 2014-12 Impact factor: 5.078
Authors: Lakshmi Goparaju; Laure S Experton; Nathan C Praschan; Lari Warren-Jeanpiere; Mary A Young; Seble Kassaye Journal: J AIDS Clin Res Date: 2015-11
Authors: Aditya Subhash Khanna; Steven Michael Goodreau; Stuart Michaels; John Alexis Schneider Journal: J Med Internet Res Date: 2018-09-14 Impact factor: 5.428
Authors: Morgan M Philbin; Sadie Bergen; Carrigan Parish; Deanna Kerrigan; Elizabeth N Kinnard; Sarah Reed; Mardge H Cohen; Oluwakemi Sosanya; Anandi N Sheth; Adaora A Adimora; Jennifer Cocohoba; Lakshmi Goparaju; Elizabeth T Golub; Michael Vaughn; José I Gutierrez; Margaret A Fischl; Maria Alcaide; Lisa R Metsch Journal: AIDS Behav Date: 2021-10-14
Authors: Laura M Johnson; Harold D Green; Minggen Lu; Jamila K Stockman; Marisa Felsher; Alexis M Roth; Karla D Wagner Journal: AIDS Behav Date: 2022-02-25
Authors: Tiara C Willie; Trace S Kershaw; Oni Blackstock; Rachel W Galvao; Cara B Safon; Mehrit Tekeste; Damon F Ogburn; Brittany Wilbourn; Djordje Modrakovic; Tamara Taggart; Clair Kaplan; Abigail Caldwell; Sarah K Calabrese Journal: AIDS Care Date: 2020-05-14
Authors: Anne M Teitelman; Hong-Van Tieu; Dalmacio Flores; Jacqueline Bannon; Bridgette M Brawner; Annet Davis; Paige Gugerty; Beryl Koblin Journal: AIDS Care Date: 2021-03-09
Authors: Laura M Johnson; Harold D Green; Brandon Koch; Jamila K Stockman; Marisa Felsher; Alexis M Roth; Karla D Wagner Journal: J Acquir Immune Defic Syndr Date: 2021-04-01 Impact factor: 3.771